Sign In
Buy ISRG
$350.06
-3.11 (-0.88%)
At Close: Jul 21, 2026
Intuitive Surgical (ISRG) Q2 Earnings Miss, Procedures Recover
10:58am, Friday, 22'nd Jul 2022
Intuitive Surgical's (ISRG) second-quarter results reflect health demand for procedures despite the resurgence of COVID-19 infections.
Intuitive Surgical Stock Is Tanking. But Analysts Like the Long-Term Story.
10:22am, Friday, 22'nd Jul 2022
The company said it was difficult to match some customer orders by the end of the second quarter because of delays in semiconductor components.
Snap, Seagate And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
10:08am, Friday, 22'nd Jul 2022 Benzinga
Snap Inc. (NYSE: SNAP) fell 28.4% to $11.70 in pre-market trading after the company reported worse-than-expected Q2 results, announced a reduction in the hiring rate and did not provide guidance.
Intu
U.S. Stock Futures Edge Lower; Verizon, Twitter Earnings in Focus
09:57am, Friday, 22'nd Jul 2022 Benzinga
Pre-open movers
U.S. stock futures traded lower in early pre-market trade on Thursday after the Nasdaq Composite jumped around 1.4% the previous session. Investors are awaiting earnings results from
Intuitive Surgical, Inc. (ISRG) Q2 Earnings and Revenues Miss Estimates
09:25pm, Thursday, 21'st Jul 2022 Zacks Investment Research
Intuitive Surgical, Inc. (ISRG) delivered earnings and revenue surprises of -1.72% and 2.53%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Intuitive Surgical Inc's (ISRG) CEO Gary Guthart on Q2 2022 Results - Earnings Call Transcript
08:40pm, Thursday, 21'st Jul 2022
Intuitive Surgical, Inc. (NASDAQ:ISRG ) Q2 2022 Earnings Conference Call July 21, 2022 4:30 PM ET Company Participants Brian King – Head-Investor Relations Gary Guthart – Chief Executive Officer J
Street is underestimating Fed aggressiveness, warns Wells Fargo Securities following ECB hike
08:36pm, Thursday, 21'st Jul 2022
Wells Fargo Securities' Michael Schumacher on the ECB's first rate hike in 10 years and what he expects from the Fed next week. With CNBC's Courtney Reagan and the Fast Money traders, Guy Adami, Tim S
Intuitive Announces Second Quarter Earnings
08:05pm, Thursday, 21'st Jul 2022 GlobeNewswire Inc.
SUNNYVALE, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery,
Intuitive Surgical, Inc. (ISRG) Q2 Earnings and Revenues Miss Estimates
06:36pm, Thursday, 21'st Jul 2022
Intuitive Surgical, Inc. (ISRG) delivered earnings and revenue surprises of -1.72% and 2.53%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Intuitive Surgical stock falls more than 13% after Q2 results fall short
04:45pm, Thursday, 21'st Jul 2022
Shares of Intuitive Surgical dropped more than 13% in the extended session Thursday after the maker of surgical robotic systems reported second-quarter results below Wall Street expectations and said
Intuitive Surgical Stock Plunges After Q2 Results Miss Street Expectation
04:41pm, Thursday, 21'st Jul 2022
Intuitive Surgical, Inc. (NASDAQ: ISRG) reported second-quarter revenue growth of 4% year-over-year to $1.52 billion, +6% on a constant currency basis, missing the consensus of $1.56 billion. The gr
Is a Surprise Coming for Intuitive Surgical (ISRG) This Earnings Season?
12:52pm, Wednesday, 20'th Jul 2022 Zacks Investment Research
Intuitive Surgical (ISRG) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Is a Surprise Coming for Intuitive Surgical (ISRG) This Earnings Season?
10:08am, Wednesday, 20'th Jul 2022
Intuitive Surgical (ISRG) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
J&J Medtech Outlook Boosts Shares of Stryker, Biomet and Intuitive
05:42pm, Tuesday, 19'th Jul 2022
While Johnson & Johnson's ( JNJ , Financial) Medtech sales were lower in the second quarter, revenue from hips and knee replacements was on target or above, a development that could spill over into se
